{"id":24775,"date":"2023-11-09T04:53:00","date_gmt":"2023-11-08T20:53:00","guid":{"rendered":"http:\/\/csccm.org.cn\/?p=24775"},"modified":"2023-11-09T05:50:18","modified_gmt":"2023-11-08T21:50:18","slug":"jama%e5%8f%91%e8%a1%a8%e8%ae%ba%e6%96%87%ef%bc%9acpap%e6%b2%bb%e7%96%97%e4%be%9d%e4%bb%8e%e6%80%a7%e4%b8%8e%e5%a4%8d%e5%8f%91%e6%80%a7%e5%bf%83%e8%a1%80%e7%ae%a1%e4%ba%8b%e4%bb%b6%e7%9a%84%e9%a3%8e","status":"publish","type":"post","link":"https:\/\/csccm.org.cn\/?p=24775","title":{"rendered":"[JAMA\u53d1\u8868\u8bba\u6587]\uff1aCPAP\u6cbb\u7597\u4f9d\u4ece\u6027\u4e0e\u590d\u53d1\u6027\u5fc3\u8840\u7ba1\u4e8b\u4ef6\u7684\u98ce\u9669"},"content":{"rendered":"\n<p>Original Investigation&nbsp;<\/p>\n\n\n\n<p>October&nbsp;3,&nbsp;2023<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis<\/h1>\n\n\n\n<h3 class=\"wp-block-heading\">Manuel\u00a0S\u00e1nchez-de-la-Torre,\u00a0Esther\u00a0Gracia-Lavedan,\u00a0Ivan D.\u00a0Benitez,\u00a0et al<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\"><em>JAMA.\u00a0<\/em>2023;330(13):1255-1265. doi:10.1001\/jama.2023.17465<\/h3>\n\n\n\n<p><a><\/a>Key Points<\/p>\n\n\n\n<p><strong>Question<\/strong>&nbsp;&nbsp;Is continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA) associated with a decreased risk of cardiovascular adverse events in participants with both OSA and established cardiovascular disease?<\/p>\n\n\n\n<p><strong>Findings<\/strong>&nbsp;&nbsp;This systematic review and individual participant data (IPD) meta-analysis of 3 randomized clinical trials including 4186 patients with IPD showed that whereas the IPD meta-analysis based on intention to treat reported no effect of CPAP treatment, the adherent use of CPAP treatment (\u22654 hours\/day) is associated with a reduced recurrence risk of major adverse cardiac or cerebrovascular events (MACCEs) with a significant hazard ratio of 0.69.<\/p>\n\n\n\n<p><strong>Meaning<\/strong>&nbsp;&nbsp;Patients with established cardiovascular disease and OSA who used CPAP for 4 or more hours per day had a significantly lower risk of MACCEs than those who used CPAP less than 4 hours per day.<a><\/a><\/p>\n\n\n\n<p>Abstract<\/p>\n\n\n\n<p><strong>Importance<\/strong>&nbsp;&nbsp;The effect of continuous positive airway pressure (CPAP) on secondary cardiovascular disease prevention is highly debated.<\/p>\n\n\n\n<p><strong>Objective<\/strong>&nbsp;&nbsp;To assess the effect of CPAP treatment for obstructive sleep apnea (OSA) on the risk of adverse cardiovascular events in randomized clinical trials.<\/p>\n\n\n\n<p><strong>Data Sources<\/strong>&nbsp;&nbsp;PubMed (MEDLINE), EMBASE, Current Controlled Trials: metaRegister of Controlled Trials, ISRCTN Registry, European Union clinical trials database, CENTRAL (Cochrane Central Register of Controlled Trials), and ClinicalTrials.gov databases were systematically searched through June 22, 2023.<\/p>\n\n\n\n<p><strong>Study Selection<\/strong>&nbsp;&nbsp;For qualitative and individual participant data (IPD) meta-analysis, randomized clinical trials addressing the therapeutic effect of CPAP on cardiovascular outcomes and mortality in adults with cardiovascular disease and OSA were included.<\/p>\n\n\n\n<p><strong>Data Extraction and Synthesis<\/strong>&nbsp;&nbsp;Two reviewers independently screened records, evaluated potentially eligible primary studies in full text, extracted data, and cross-checked errors. IPD were requested from authors of the selected studies (SAVE [<a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00738179\">NCT00738179<\/a>], ISAACC [<a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01335087\">NCT01335087<\/a>], and RICCADSA [<a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00519597\">NCT00519597<\/a>]).<\/p>\n\n\n\n<p><strong>Main Outcomes and Measures<\/strong>&nbsp;&nbsp;One-stage and 2-stage IPD meta-analyses were completed to estimate the effect of CPAP treatment on risk of recurrent major adverse cardiac and cerebrovascular events (MACCEs) using mixed-effect Cox regression models. Additionally, an on-treatment analysis with marginal structural Cox models using inverse probability of treatment weighting was fitted to assess the effect of good adherence to CPAP (\u22654 hours per day).<\/p>\n\n\n\n<p><strong>Results<\/strong>\u00a0\u00a0A total of 4186 individual participants were evaluated (82.1% men; mean [SD] body mass index, 28.9 [4.5]; mean [SD] age, 61.2 [8.7] years; mean [SD] apnea-hypopnea index, 31.2 [17] events per hour; 71% with hypertension; 50.1% receiving CPAP [mean {SD} adherence, 3.1 {2.4} hours per day]; 49.9% not receiving CPAP [usual care], mean [SD] follow-up, 3.25 [1.8] years). The main outcome was defined as the first MACCE, which was similar for the CPAP and no CPAP groups (hazard ratio, 1.01 [95% CI, 0.87-1.17]). However, an on-treatment analysis by marginal structural model revealed a reduced risk of MACCEs associated with good adherence to CPAP (hazard ratio, 0.69 [95% CI, 0.52-0.92]).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939235\/joi230106f1_1696283230.8356.png?Expires=1699480103&amp;Signature=3IL-dLoHIGVsTJB7zjbohjRq~GumQACUgiSpAAPbR7n-MqY1g31msY~fEWNuzDbd1f2w85SCygYZvLQAwlbE78Yurnn70qOCadHadN9qwR51ZKCwDsTefSwU7VMl-OXdNTlH3VYsA46o62OcgjjlS0l7dy4C2jjZ6XOpX4Op2osThrUopekWzZc8Qh4tVktUVtfIxGW5QlTh-p8qZGrH127HltxKc7lzvMfrYSUctC0uxqQ8TBQYrUjnzZDRnvMp5NpXGpUHVvf80dYr7lyGhgrk~T2CaHuJiG0T9n7wz-yKxTAND-gjtsZgKhyTkUH~3asYvePUft9uiJHDl6TlSA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939235\/joi230106f2_1696283231.09668.png?Expires=1699480103&amp;Signature=jQ9gBP3pY1BkEjzqkKL58uQxrHvl3ul3Ya-KIpHehOgP-oebiHXW1xjAySCTb5y3LLgHVz~X9Yq3ZFl4pIBTlmO8x8ddmTbZiyW2g4Uk9Jai1ft3nCzO2qIzD3-JlM7QpKCiSh9QGYMrou1twjenqLPGOMZQzmYqoaqpKs2giZKaM8XaZDuEcQ8E4nZu2ineUj0o0GgPS7X7wStdyWtL9HxGAWM7UlvKbwyu-8gyD5qFVJPiIr2g42BXoN49KzBpbsMm9OQg5YYIO1XXCIcla8o9r2KTZI1ZJbsRm-TJZTRup5HJEBVSPcGALsIt8bSDSIct4ndNWFfpNA5iKXHaNQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939235\/joi230106f3_1696283231.12169.png?Expires=1699480103&amp;Signature=yIrJHNOZGNb2SsNYp3jiH8sln88uliZym2PIyztzY1rULG4Hflz41p1V1pIU3qwPGsdkwTsgGU9nQ3wsYdNoawXqhKSBvaVNLLlujnzPvRfzdN3ezHQgcGzy8McTRDu-G6mYNWKtja~EHMoQev1HSioTtYAIC6SNC6oQfE3Abg2gk5ekNq46u8-NnFp0Hpfotu7~vd37bO42TTCIlDkZU38VLjkv0l04IQqx9yhGEfShrH0BmpA12HF-DBA1dIk8CDxaJu5lYqGpySQB6s4LhiipXlVEQK2t-1~3-BnO6-Ae~F4oJxNIcBrfePaPW0-9Uf81N0b~Tur2Yq7cZPlkSA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939235\/joi230106t1_1696283231.0206.png?Expires=1699480103&amp;Signature=z9f8eU~nQwWf8A2SULWO4HT9SThhqnE3SJIXmBSxaMss2eeuQpeSZ7mOzm7NejiPN9uqBt1zQJK3CIoMbN-BjxRMLprn03yDUfD074muWN-5Vbgw44wd9M5HuP67jbZVJOUX6qp8R~Pnb3DRL4BIPtfte9SnI2s9E~DbEjDIO0JTpBzQOcnPcVC3C40ruSX64aaaMnBV9TF0Iq95AWzZhI6szjdg8u8KcMpdrca~r19gyK02wmOmNBytWV-QxuRIc~xqA8~s1OMtdWr-7e2~2gy~rlOUScOrOiRMvCzKpsvE6YzKpDEEcWAzLJZ911ASTP1SkUzeahWWTuTypXFs9A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jama\/939235\/joi230106t2_1696283231.04672.png?Expires=1699480103&amp;Signature=Uwuvg5DhBEzhP7aIfsYMyAckjJboYR9iqIrF3ZD287s2HpjRrlg9kMXSMSdD8riq5maKC14hMKdnVZnhYPyfEDe7Sjllr59YMwY~8sDXyR7mndKM~7dq1CkrneQwJ3citPpnNr3ePGRzPrtD8Xx4E0EaP-wz71xlw4JQtHZq77YkGfIclq0MEKpy-vS0qV201kx1S8BT94NkXs6XmbV0DfjY7GGbV96cv5ZkJk~GvkhsQ4Pne45F0PL2Nc6OwE0Cr1q1VfvhPRMjqLCQIHM3OBlf-lDxKUKT5zhLfSUthjw1pwwIbh8NXcsqWLB9ykAzn2M5UWIQxOzEDPurm-Olig__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<p><strong>Conclusions and Relevance<\/strong>&nbsp;&nbsp;Adherence to CPAP was associated with a reduced MACCE recurrence risk, suggesting that treatment adherence is a key factor in secondary cardiovascular prevention in patients with OSA.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original Investigation&nbsp; October&nbsp;3,&nbsp;2023  [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[32,23],"tags":[],"_links":{"self":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/24775"}],"collection":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24775"}],"version-history":[{"count":1,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/24775\/revisions"}],"predecessor-version":[{"id":24776,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/24775\/revisions\/24776"}],"wp:attachment":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}